cloudy.png
Monday May 17th, 2021 3:54PM

Scientists get closer to blood test for Alzheimer's disease

By The Associated Press

An experimental blood test was highly accurate at distinguishing people with Alzheimer’s disease from those without it in several studies, boosting hopes that there soon may be a simple way to help diagnose this most common form of dementia.

Developing such a test has been a long-sought goal, and scientists warn that the new approach still needs more validation and is not yet ready for wide use.

But Tuesday’s results suggest they’re on the right track. The testing identified people with Alzheimer’s vs. no dementia or other types of it with accuracy ranging from 89% to 98%.

“That’s pretty good. We’ve never seen that” much precision in previous efforts, said Maria Carrillo, the Alzheimer’s Association’s chief science officer.

Dr. Eliezer Masliah, neuroscience chief at the U.S. National Institute on Aging, agreed.

“The data looks very encouraging,” he said. The new testing “appears to be even more sensitive and more reliable” than earlier methods, but it needs to be tried in larger, more diverse populations, he said.

The institute had no role in these studies but financed earlier, basic research toward blood test development.

Results were discussed at the Alzheimer’s Association International Conference taking place online because of the coronavirus pandemic. Some results also were published in the Journal of the American Medical Association.

More than 5 million people in the United States and many more worldwide have Alzheimer’s. Current drugs only temporarily ease symptoms and do not slow mental decline.

The disease is usually diagnosed through tests of memory and thinking skills, but that’s very imprecise and usually involves a referral to a neurologist. More reliable methods such as spinal fluid tests and brain scans are invasive or expensive, so a simple blood test that could be done in a family doctor's office would be a big advance.

Last year, scientists reported encouraging results from experimental blood tests that measure abnormal versions of amyloid, one of two proteins that build up and damage Alzheimer’s patients’ brains. The new work focuses on the other protein — tau — and finds that one form of it called p-tau217 is a more reliable indicator. Several companies and universities have developed experimental p-tau217 tests.

Dr. Oskar Hansson of Lund University in Sweden led a study of Eli Lilly’s test on more than 1,400 people already enrolled in dementia studies in Sweden, Arizona and Colombia. They included people with no impairment, mild impairment, Alzheimer’s and other neurological diseases.

The p-tau217 test outperformed a host of other measures for indicating which patients had Alzheimer’s as verified by brain scans. It also was comparable to the brain scans and some spinal tests in accuracy.

The Arizona portion of the study included 81 people who had donated their brains upon death, so researchers were able to show that blood testing while they were alive closely matched evidence of disease later.

The Colombia part of the study included people with a rare gene that virtually destines them to develop Alzheimer’s at a young age, typically in their 40s. In those with the gene, p-tau217 blood levels started to rise “around 20 years before symptoms,” Hansson said.

The study’s sponsors include the U.S. National Institutes of Health, Swedish government health groups, the Alzheimer’s Association, many foundations and several companies. Some study leaders work for Lilly or consult for the company.

Two other research groups independently reported evidence for p-tau217 testing at the conference.

Scientists at the University of California, San Francisco, found it helped distinguish people with Alzheimer’s from those with another neurological disease — frontotemporal lobar degeneration — with 96% accuracy in a study of 617 people.

Dr. Suzanne Schindler of Washington University in St. Louis, Missouri, also found p-tau217 better than some other indicators for revealing which patients had plaques in the brain — the hallmark of Alzheimer’s.

“When patients come to me with changes in their memory and thinking, one of the major questions is, what’s the cause? Is it Alzheimer’s disease or is it something else?” she said. If tau testing bears out, “it would help us diagnose people earlier and more accurately.”

Schindler has already launched a larger study in a diverse population in St. Louis. Researchers have done the same in Sweden.

If benefits are confirmed, Masliah, Carrillo and others say they hope a commercial test would be ready for wide use in about two years.

___

Marilynn Marchione can be followed on Twitter at http://twitter.com/MMarchioneAP

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

  • Associated Categories: Associated Press (AP), AP National News, AP Online National News, Top General short headlines, AP Health, AP Business, AP Health - Senior Health
© Copyright 2021 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
Struggling merchants, insurers battle over pandemic coverage
Restaurants, bars and other merchants struggling to stay afloat during the coronavirus pandemic are desperately reaching out for a lifeline from insurers who say they are being miscast as potential saviors
8:10PM ( 14 minutes ago )
McConnell: No room for new FBI building in virus aid bill
The Senate’s top Republican says he opposes a push by President Donald Trump to include nearly $1.8 billion in a new coronavirus aid package to rebuild the FBI headquarters in downtown Washington
8:06PM ( 17 minutes ago )
Biden's notes: ‘Do not hold grudges’ against Kamala Harris
Joe Biden didn’t want to say much Tuesday about his vice presidential search, but Democrats’ presumptive presidential nominee was prepared nonetheless to talk about potentially sensitive politics around one of the top contenders: Kamala Harris
7:55PM ( 28 minutes ago )
Associated Press (AP)
Trump administration won't accept new DACA applications
The Trump administration says it will reject new applications and shorten renewal periods for an Obama-era program that shields young people from deportation
7:08PM ( 1 hour ago )
Trump defends disproved COVID-19 treatment
President Donald Trump has issued a stout defense of a disproved use of a malaria drug as a treatment for the coronavirus, hours after social media companies moved to take down videos promoting its use as potentially harmful misinformation
6:48PM ( 1 hour ago )
US officials: Russia behind spread of virus disinformation
The U.S. government has identified two suspected Russian military intelligence operatives who it believes are helping direct the spread of disinformation through websites that have published extensively on the coronavirus pandemic, American politics and international affairs
6:20PM ( 2 hours ago )
AP National News
Trump's coronavirus retweets spark claims of censorship
President Donald Trump’s sharing of misinformation about the coronavirus and removal of the material by social media platforms have sparked claims of censorship by some doctors and others
5:17PM ( 3 hours ago )
Baseball season teeters, while states resist mask rules
The baseball season descended deeper into crisis Tuesday, while states such as Mississippi and South Carolina looked for ways to add hospital beds
5:12PM ( 3 hours ago )
US officials tell AP: Russia spreading virus disinformation
The U.S. government has identified two suspected Russian military intelligence operatives who it believes are helping direct the spread of disinformation through websites that have published extensively on the coronavirus pandemic, American politics and international affairs
5:07PM ( 3 hours ago )
AP Online National News
Masked mourners brave heat, virus fears to honor John Lewis
Mourners have braved coronavirus fears and brutal heat to pay their respects to the late Rep. John Lewis outside the U.S. Capitol
5:15PM ( 3 hours ago )
Space Camp in danger of closing permanently due to pandemic
A popular educational program called "Space Camp" is in danger of closing because of the coronavirus pandemic
4:37PM ( 3 hours ago )
Barr, Park Police distance Trump from clearing of protesters
The head of U.S. Park Police is denying that his officers violently turned on protesters near the White House to clear the area for a photo event by President Donald Trump
3:39PM ( 4 hours ago )
Top General short headlines
The Latest: Number of new virus cases drops in Minnesota
Minnesota health officials say the number of newly confirmed coronavirus case slipped after several days of large case counts
6:51PM ( 1 hour ago )
The Latest: Tennessee gov prefers opening schools in-person
Tennessee Gov. Bill Lee has announced that reopening schools in-person is the “medically sound, preferred option,” but he said it’s dependent on quickly isolating those who are sick and quarantining their close contacts
6:40PM ( 1 hour ago )
The Latest: Arkansas reports one-day high in COVID-19 deaths
Arkansas has reported a new one-day high deaths from the illness caused by the coronavirus, and the state’s virus cases have exceeded 40,000
6:18PM ( 2 hours ago )
AP Health
Rembrandt, Miro fetch millions at Sotheby's virtual auction
A self-portrait by Rembrandt has sold for 14.5 million pounds ($18.7 million) at a Sotheby’s virtual auction
7:30PM ( 53 minutes ago )
Democrats, GOP far apart on virus aid; Trump wants a deal
The differences in Washington over the next coronavirus aid package are vast
7:24PM ( 59 minutes ago )
Starbucks says it sees better times ahead as stores reopen
Starbucks’ revenue shrank 38% in its most recent quarter but the coffee giant says it’s recovering faster than expected as its stores reopen from coronavirus lockdowns
7:20PM ( 1 hour ago )
AP Business
With no new law to curb drug costs, Trump tries own changes
President Donald Trump has been unable to land the big deal he sought with Congress to curb drug costs
12:18AM ( 3 days ago )
With no deal to curb drug costs, Trump tries his own changes
President Donald Trump has been unable to land the big deal with Congress to curb drug costs
3:30PM ( 4 days ago )
Cognitive Test. Trump. Biden. Campaign. Flashpoint.
President Donald Trump is boasting about his performance on a "mental fitness' test
1:05AM ( 4 days ago )
AP Health - Senior Health
Struggling merchants, insurers battle over pandemic coverage
Restaurants, bars and other merchants struggling to stay afloat during the coronavirus pandemic are desperately reaching out for a lifeline from insurers who say they are being miscast as potential saviors
8:10PM ( 14 minutes ago )
McConnell: No room for new FBI building in virus aid bill
The Senate’s top Republican says he opposes a push by President Donald Trump to include nearly $1.8 billion in a new coronavirus aid package to rebuild the FBI headquarters in downtown Washington
8:06PM ( 18 minutes ago )
Biden's notes: ‘Do not hold grudges’ against Kamala Harris
Joe Biden didn’t want to say much Tuesday about his vice presidential search, but Democrats’ presumptive presidential nominee was prepared nonetheless to talk about potentially sensitive politics around one of the top contenders: Kamala Harris
7:55PM ( 28 minutes ago )
Source: US, Oregon in talks about pulling agents in Portland
A senior White House official says the Trump administration has started talks with the Oregon governor’s office and indicated that it would begin to draw down the presence of federal agents in Portland if the state steps up its own enforcement
7:48PM ( 35 minutes ago )
Biden vows to fight racial inequality with economic agenda
Democratic presidential candidate Joe Biden is promising that his economic agenda will combat long-standing racial inequalities as he seeks to draw another sharp contrast with President Donald Trump
7:40PM ( 44 minutes ago )